VolitionRx Limited announced that it will receive $100,000 in funding on March 12, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 USD | +10.45% | +2.78% | +3.21% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.21% | 55.49M | |
-43.04% | 7.91B | |
+12.75% | 3.68B | |
-20.15% | 1.97B | |
-22.61% | 1.6B | |
+23.82% | 1.12B | |
+24.08% | 777M | |
-11.14% | 687M | |
-29.59% | 514M | |
-0.40% | 290M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it expects to receive $0.1 million in funding